Literature DB >> 2029443

Factors influencing the persistence of shunting within 24 hours of catheter occlusion of the ductus arteriosus.

R Vitiello1, L Benson, N Musewe, R Freedom.   

Abstract

Catheter occlusion of the persistent ductus arteriosus recently became clinically available with a Rashkind (USCI Bellerica, Massachusetts, USA) umbrella occluder system. A few patients, however, had residual left to right shunting after the procedure. The impact of soaking the foam of the device in a thrombin solution to enhance clotting and of using a device with a diameter of 12 or 17 mm was assessed in 117 consecutive patients undergoing catheter closure. The frequency of residual shunting detected by colour flow Doppler 24 hours after the procedure was the same whether or not thrombin was used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029443      PMCID: PMC1024582          DOI: 10.1136/hrt.65.4.211

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

1.  Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion.

Authors:  A Krichenko; L N Benson; P Burrows; C A Möes; P McLaughlin; R M Freedom
Journal:  Am J Cardiol       Date:  1989-04-01       Impact factor: 2.778

2.  Outpatient closure of the patent ductus arteriosus.

Authors:  D L Wessel; J F Keane; I Parness; J E Lock
Journal:  Circulation       Date:  1988-05       Impact factor: 29.690

3.  Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis.

Authors:  N N Musewe; L N Benson; J F Smallhorn; R M Freedom
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

4.  Catheter occlusion of the persistently patent ductus arteriosus.

Authors:  J D Dyck; L N Benson; J F Smallhorn; P R McLaughlin; R M Freedom; R D Rowe
Journal:  Am J Cardiol       Date:  1988-11-15       Impact factor: 2.778

5.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

6.  Transcatheter closure of patent ductus arteriosus in pediatric patients.

Authors:  L A Latson; P J Hofschire; J D Kugler; J P Cheatham; C H Gumbiner; D A Danford
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

  6 in total
  2 in total

1.  Total UK multi-centre experience with a novel arterial occlusion device (Duct Occlud pfm).

Authors:  A Tometzki; K Chan; J De Giovanni; A Houston; R Martin; D Redel; A Redington; M Rigby; J Wright; N Wilson
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

Review 2.  Paediatric cardiac catheterization: innovations.

Authors:  J J Javorski; D D Hansen; P C Laussen; M L Fox; J Lavoie; F A Burrows
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.